Citadel Advisors
FBIO icon

Citadel Advisors’s Fortress Biotech FBIO Stock Holding History

Citadel Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$179K Buy
58,400
+29,300
+101% +$75.6K ﹤0.01% 12193
2026
Q1 		$81.2K Sell
29,100
-31,800
-52% -$108K ﹤0.01% 12162
2025
Q4 		$223K Buy
+60,900
New +$174K ﹤0.01% 10802
2025
Q2 		– Sell
-66,900
Closed -$104K – 13253
2025
Q1 		$104K Sell
66,900
-12,500
-16% -$22K ﹤0.01% 11393
2024
Q4 		$161K Buy
79,400
+71,700
+931% +$130K ﹤0.01% 10780
2024
Q3 		$11.1K Buy
7,700
+4,600
+148% +$8.76K ﹤0.01% 13169
2024
Q2 		$5.3K Sell
3,100
-6,600
-68% -$12K ﹤0.01% 13412
2024
Q1 		$19.4K Sell
9,700
-5,300
-35% -$10.5K ﹤0.01% 13036
2023
Q4 		$45.1K Buy
15,000
+14,847
+9,704% +$39.3K ﹤0.01% 11888
2023
Q3 		$668 Sell
153
-87
-36% -$597 ﹤0.01% 14007
2023
Q2 		$1.98K Buy
240
+53
+28% +$524 ﹤0.01% 13847
2023
Q1 		$2.3K Buy
+187
New +$2.23K ﹤0.01% 14171
2022
Q3 		– Sell
-1,307
Closed -$16K – 12893
2022
Q2 		$16K Sell
1,307
-4,153
-76% -$61.5K ﹤0.01% 12477
2022
Q1 		$111K Sell
5,460
-120
-2% -$3.29K ﹤0.01% 12173
2021
Q4 		$209K Buy
5,580
+467
+9% +$20.8K ﹤0.01% 11759
2021
Q3 		$247K Buy
5,113
+626
+14% +$30.6K ﹤0.01% 11504
2021
Q2 		$240K Buy
+4,487
New +$271K ﹤0.01% 11779
2015
Q4 		– Sell
-320
Closed -$12K – 8837
2015
Q3 		$12K Sell
320
-113
-26% -$5.28K ﹤0.01% 8401
2015
Q2 		$22K Sell
433
-134
-24% -$6.88K ﹤0.01% 8103
2015
Q1 		$33K Buy
+567
New +$23.6K ﹤0.01% 7635
2014
Q3 		– Sell
-340
Closed -$9K – 8193
2014
Q2 		$9K Sell
340
-80
-19% -$2.11K ﹤0.01% 7599
2014
Q1 		$12K Sell
420
-7
-2% -$273 ﹤0.01% 7459
2013
Q4 		$17K Buy
+427
New +$16.5K ﹤0.01% 6549

Other funds holding FBIO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors's FBIO Position: Q2 2026 in Review

Citadel Advisors reduced its Fortress Biotech (FBIO) stake by 57% in Q2 2026, selling an estimated $266K and leaving 77,065 shares worth $236K. The position accounts for ﹤0.01% of the portfolio, ranked #11677.

Citadel Advisors first reported a position in FBIO in Q3 2013 and has held it in 26 quarters since. The position peaked at $503K in Q1 2026. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Citadel Advisors held 77,065 shares of Fortress Biotech worth $236K as of Q2 2026.
  • Citadel Advisors sold 103,224 Fortress Biotech shares in Q2 2026, an estimated $266K.
  • Fortress Biotech made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11677 holding.
  • Citadel Advisors first reported a position in Fortress Biotech in Q3 2013 and has held it in 26 quarters since.
  • Citadel Advisors's Fortress Biotech position peaked at $503K in Q1 2026.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.